Home Medical Devices India IVD Raw Materials Market

India IVD Raw Materials Market Size, Share & Trends Analysis Report By Product (Antibody, Antigens, Proteins, Enzymes, Biological Buffers, Substrates, Others), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunochemistry, Others), By End User (Diagnostic Laboratories, Pharmaceutical & Biotechnological Companies, Others) and Forecasts, 2025-2033

Last Updated: October 25, 2024 | Author: Mitiksha Koul | Format: | Report Code: SRMD56521DR | Pages: 80

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  2. ESG Trends
  3. ESG Trends
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Antibody
        1. By Value
      3. Antigens
        1. By Value
      4. Proteins
        1. By Value
      5. Enzymes
        1. By Value
      6. Biological Buffers
        1. By Value
      7. Substrates
        1. By Value
      8. Others
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Molecular Diagnostics
        1. By Value
      3. Clinical Chemistry
        1. By Value
      4. Immunochemistry
        1. By Value
      5. Others
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Pharmaceutical & Biotechnological Companies
        1. By Value
      4. Others
        1. By Value
    5. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Antibody
          1. By Value
        3. Antigens
          1. By Value
        4. Proteins
          1. By Value
        5. Enzymes
          1. By Value
        6. Biological Buffers
          1. By Value
        7. Substrates
          1. By Value
        8. Others
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Molecular Diagnostics
          1. By Value
        3. Clinical Chemistry
          1. By Value
        4. Immunochemistry
          1. By Value
        5. Others
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Pharmaceutical & Biotechnological Companies
          1. By Value
        4. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Antibody
        1. By Value
      3. Antigens
        1. By Value
      4. Proteins
        1. By Value
      5. Enzymes
        1. By Value
      6. Biological Buffers
        1. By Value
      7. Substrates
        1. By Value
      8. Others
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Molecular Diagnostics
        1. By Value
      3. Clinical Chemistry
        1. By Value
      4. Immunochemistry
        1. By Value
      5. Others
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Pharmaceutical & Biotechnological Companies
        1. By Value
      4. Others
        1. By Value
    5. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Antibody
          1. By Value
        3. Antigens
          1. By Value
        4. Proteins
          1. By Value
        5. Enzymes
          1. By Value
        6. Biological Buffers
          1. By Value
        7. Substrates
          1. By Value
        8. Others
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Molecular Diagnostics
          1. By Value
        3. Clinical Chemistry
          1. By Value
        4. Immunochemistry
          1. By Value
        5. Others
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Pharmaceutical & Biotechnological Companies
          1. By Value
        4. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Antibody
        1. By Value
      3. Antigens
        1. By Value
      4. Proteins
        1. By Value
      5. Enzymes
        1. By Value
      6. Biological Buffers
        1. By Value
      7. Substrates
        1. By Value
      8. Others
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Molecular Diagnostics
        1. By Value
      3. Clinical Chemistry
        1. By Value
      4. Immunochemistry
        1. By Value
      5. Others
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Pharmaceutical & Biotechnological Companies
        1. By Value
      4. Others
        1. By Value
    5. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Antibody
          1. By Value
        3. Antigens
          1. By Value
        4. Proteins
          1. By Value
        5. Enzymes
          1. By Value
        6. Biological Buffers
          1. By Value
        7. Substrates
          1. By Value
        8. Others
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Molecular Diagnostics
          1. By Value
        3. Clinical Chemistry
          1. By Value
        4. Immunochemistry
          1. By Value
        5. Others
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Pharmaceutical & Biotechnological Companies
          1. By Value
        4. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Antibody
        1. By Value
      3. Antigens
        1. By Value
      4. Proteins
        1. By Value
      5. Enzymes
        1. By Value
      6. Biological Buffers
        1. By Value
      7. Substrates
        1. By Value
      8. Others
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Molecular Diagnostics
        1. By Value
      3. Clinical Chemistry
        1. By Value
      4. Immunochemistry
        1. By Value
      5. Others
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Pharmaceutical & Biotechnological Companies
        1. By Value
      4. Others
        1. By Value
    5. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Antibody
          1. By Value
        3. Antigens
          1. By Value
        4. Proteins
          1. By Value
        5. Enzymes
          1. By Value
        6. Biological Buffers
          1. By Value
        7. Substrates
          1. By Value
        8. Others
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Molecular Diagnostics
          1. By Value
        3. Clinical Chemistry
          1. By Value
        4. Immunochemistry
          1. By Value
        5. Others
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Pharmaceutical & Biotechnological Companies
          1. By Value
        4. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Antibody
        1. By Value
      3. Antigens
        1. By Value
      4. Proteins
        1. By Value
      5. Enzymes
        1. By Value
      6. Biological Buffers
        1. By Value
      7. Substrates
        1. By Value
      8. Others
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Molecular Diagnostics
        1. By Value
      3. Clinical Chemistry
        1. By Value
      4. Immunochemistry
        1. By Value
      5. Others
        1. By Value
    4. By End User
      1. Introduction
        1. End User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Pharmaceutical & Biotechnological Companies
        1. By Value
      4. Others
        1. By Value
    5. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Antibody
          1. By Value
        3. Antigens
          1. By Value
        4. Proteins
          1. By Value
        5. Enzymes
          1. By Value
        6. Biological Buffers
          1. By Value
        7. Substrates
          1. By Value
        8. Others
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Molecular Diagnostics
          1. By Value
        3. Clinical Chemistry
          1. By Value
        4. Immunochemistry
          1. By Value
        5. Others
          1. By Value
      3. By End User
        1. Introduction
          1. End User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Pharmaceutical & Biotechnological Companies
          1. By Value
        4. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. India IVD Raw Materials Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Creative Diagnostics
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Merck KGaA
    3. Thermo Fisher Scientfic Inc.
    4. OYC Americas, Inc.
    5. Fapon Biotech Inc.
    6. Biosynth
    7. F. Hoffmann-La Roche Ltd
    8. Sysmex Corporation
    9. Shenzhen AIVD Biotechnology Co., LTD.
    10. Glentham®f Life Sciences Limited
    11. Neogen Corporation
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  4. Disclaimer
Get This Report

Download Free Sample

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.